doi: 10.2337/dc06-1628.
Transfer to sulphonylurea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating [corrected] mutations: evidence for improvement in insulin sensitivity
Affiliations
- PMID: 17192350
- DOI: 10.2337/dc06-1628
Item in Clipboard
Transfer to sulphonylurea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating [corrected] mutations: evidence for improvement in insulin sensitivity
Diabetes Care.
2007 Jan.
Erratum in
- Diabetes Care. 2007 Feb;30(2):455
No abstract available
Similar articles
-
Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a new KCNJ11 mutation.Diabetes Res Clin Pract. 2011 Jan;91(1):e1-3. doi: 10.1016/j.diabres.2010.09.027. Epub 2010 Nov 5. Diabetes Res Clin Pract. 2011. PMID: 21056492
-
Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.Pediatr Diabetes. 2008 Jun;9(3 Pt 1):236-9. doi: 10.1111/j.1399-5448.2007.00316.x. Epub 2008 Jan 24. Pediatr Diabetes. 2008. PMID: 18221420
-
Sulfonylrea treatment in permanent neonatal diabetes due to G53D mutation in the KCNJ11 gene: improvement in glycemic control and neurological function.Diabetes Care. 2007 Nov;30(11):e108. doi: 10.2337/dc07-1196. Diabetes Care. 2007. PMID: 17965292 No abstract available.
-
[Neonatal diabetes mellitus].Duodecim. 2011;127(6):534-41. Duodecim. 2011. PMID: 21528518 Review. Finnish.
-
Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences.Diabetes Metab. 2006 Dec;32(6):569-80. doi: 10.1016/S1262-3636(07)70311-7. Diabetes Metab. 2006. PMID: 17296510 Review.
Cited by
-
Associations of ATP-Sensitive Potassium Channel's Gene Polymorphisms With Type 2 Diabetes and Related Cardiovascular Phenotypes.Front Cardiovasc Med. 2022 Mar 23;9:816847. doi: 10.3389/fcvm.2022.816847. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35402560 Free PMC article.
-
Successful transition from insulin to sulfonylurea, on second attempt, in a 24-year-old female with neonatal diabetes secondary to KCNJ11 gene mutation.BMJ Case Rep. 2021 Apr 9;14(4):e239973. doi: 10.1136/bcr-2020-239973. BMJ Case Rep. 2021. PMID: 33837025 Free PMC article.
-
Three Novel Mutations I65S, R66S, and G86R Divulge Significant Conformational Variations in the PTB Domain of the IRS1 Gene.ACS Omega. 2019 Jan 29;4(1):2217-2224. doi: 10.1021/acsomega.8b01712. eCollection 2019 Jan 31. ACS Omega. 2019. PMID: 31660472 Free PMC article.
-
Precision Medicine: Long-Term Treatment with Sulfonylureas in Patients with Neonatal Diabetes Due to KCNJ11 Mutations.Curr Diab Rep. 2019 Jun 27;19(8):52. doi: 10.1007/s11892-019-1175-9. Curr Diab Rep. 2019. PMID: 31250216 Free PMC article. Review.
-
Switching to sulphonylureas in children with iDEND syndrome caused by KCNJ11 mutations results in improved cerebellar perfusion.Diabetes Care. 2013 Aug;36(8):2311-6. doi: 10.2337/dc12-2166. Epub 2013 Mar 5. Diabetes Care. 2013. PMID: 23462667 Free PMC article.
